GlaxoSmithKline (GSK) announced that its new, novel topical antibiotic ALTARGO? (retapamulin ointment, 1%) received a positive opinion from the European Committee for Human Medicinal Products (CHMP) for the treatment of impetigo and infected small lacerations, abrasions or sutured wounds.
An international study using ultrasound technology has found that the most potent cholesterol-lowering drug is also effective at halting early changes in the blood vessels that can lead to atherosclerosis.
Healthcare experts will discuss the challenges and opportunities of RFID technology in health care and its implications on government policy during the first IEEE International RFID Conference (IEEE RFID 2007).
The research presented links theory and technology from artificial intelligence, cognitive science, and computer science with theory and practice from education and social science to bring a wide range of tools to bear on the task of creating systems to help people learn.
WellPoint, Inc. (NYSE: WLP) announced the appointment of Nancy V. Atkins as vice president of Account Management in its State Sponsored Business Unit, responsible for the leadership and oversight of relationships at regulatory agencies across the country.
Scientists at WEHI have made a discovery with potentially profound implications for the care of patients, especially those undergoing cancer chemotherapy.
Sickness or injury can leave people in serious financial jeopardy even when they have health insurance, according to a report released today by the Access Project and Brandeis University. The Illusion of Coverage: How Health Insurance Fails People When They Get Sick, reports findings based on in-depth interviews with dozens of insured Americans in seven states.
Cutting junior doctors’ working hours and giving them more rest breaks won’t by itself reduce fatigue or the attendant risk of error, concludes a study published ahead of print in Occupational and Environmental Medicine.
HIV-positive men who have sex with men are up to 90 times more likely than the general population to develop anal cancer. Detection of precancerous changes (anal dysplasia) by anal cytology ? essentially an anal canal Pap smear ? is a relatively new procedure and one that has yet to enter standard practice.
The U.S. Food and Drug Administration (FDA) announced new draft guidance that would implement a more stringent approach for considering potential conflicts of interest for its advisory committee members and for recommending eligibility for meeting participation. FDA is accepting public comments on the proposal for the next 60 days.